ReviewAnticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
References (124)
- et al.
Placebocontrolled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation
Lancet
(1989) - et al.
Canadian Atrial Fibrillation Anticoagulation (CAFA) Study
J Am Coll Cardiol
(1991) Rules of evidence and clinical recommendations on the use of antithrombotic agents
Chest
(1989)- et al.
Hemorrhagic complications of long-term anticoagulant therapy
Chest
(1989) - et al.
The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy
J Clin Epidemiol
(1989) - et al.
Optimal therapeutic range for oral anticoagulant therapy
Chest
(1989) - et al.
“Therapeutic range” for oral anticoagulant therapy
Chest
(1986) - et al.
Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy
Am J Med
(1987) - et al.
Long-term anticoagulant therapy after myocardial infarction
Lancet
(1962) - et al.
Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves
J Thorac Cardiovasc Surg
(1976)
Therapeutic level in long-term anticoagulant therapy after myocardial infarction: its relation to recurrent infarction and sudden death
Am J Cardiol
(1963)
Randomized prospective trial comparing the native prothrombin antigen with the prothrombin time for monitoring oral anticoagulant therapy
Blood
(1990)
Duration of warfarin anticoagulant therapy and the probabilities of recurrent thromboembolism and hemorrhage
Am J Med
(1986)
Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin
J Clin Epidemiol
(1989)
Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole
Am J Cardiol
(1983)
Hematological complications with the St. Jude valve and reduced-dose coumadin
Ann Thorac Surg
(1989)
Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy
Am J Med
(1989)
Massive hemorrhage complicating age-related macular degeneration: clinicopathologic correlation and role of anticoagulants
Ophthalmology
(1986)
Anticoagulants and cataract surgery
J Cataract Refract Surg
(1988)
A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy
Am J Med
(1990)
Heparin therapy: a randomized prospective study
Am Heart J
(1979)
Heparin therapy in venous thromboembolism
Am J Med
(1981)
An objective study of alternative methods of heparin administration
Thromb Res
(1980)
Heparin therapy for deep venous thrombosis
Am J Surg
(1980)
Comparison of the native prothrombin antigen and the prothrombin time for monitoring oral anticoagulant therapy
Blood
(1984)
Heparin therapy in thromboembolic disease
Lancet
(1966)
Stroke prevention in atrial fibrillation study: final results
Circulation
(1991)
The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
N Engl J Med
(1990)
The effect of warfarin on mortality and reinfarction after myocardial infarction
N Engl J Med
(1990)
Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery
BMJ
(1987)
Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery
N Engl J Med
(1988)
The impact of long-term warfarin therapy on quality of life: evidence from a randomized trial
Arch Intern Med
(1991)
Reliance on prothrombin time ratios causes significant errors in anticoagulation therapy
Arch Intern Med
(1992)
Aspirin, heparin, or both to treat acute unstable angina
N Engl J Med
(1988)
Prediction of bleeding during heparin therapy
JAMA
(1980)
Hemorrhagic complications of anticoagulant therapy
Arch Intern Med
(1974)
A double-blind trial of long-term anticoagulant treatment after myocardial infarction
Acta Med Scand
(1967)
An evaluation of anticoagulant therapy in the treatment of cerebrovascular disease: report of the Veterans Administration Cooperative Study of Atherosclerosis
Neurology
(1961)
Long-term anticoagulant therapy in patients with cerebral infarction
Acta Med Scand
(1965)
Anticoagulant therapy: five years experience with the patient with an established cerebrovascular accident
Arch Neurol
(1963)
Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement
Lancet
(1988)
Trial of different intensities of anticoagulation in patients with prosthetic heart valves
N Engl J Med
(1990)
Double blind trial of long-term anticoagulant treatment after myocardial infarction
Acta Med Scand
(1969)
Home prothrombin time monitoring after the initiation of warfarin therapy: a randomized, prospective study
Ann Intern Med
(1989)
Low-dose heparin therapy in the long-term management of venous thromboembolism
Am J Med
(1979)
Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis
N Engl J Med
(1979)
Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis
N Engl J Med
(1982)
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis
N Engl J Med
(1982)
Heparin for five days as compared with ten days in the initial treatment of proximal venous thrombosis
N Engl J Med
(1990)
An audit of anticoagulation and endocarditis prophylaxis after heart valve surgery
N Z Med J
(1991)
Cited by (808)
Barriers to Guideline-Directed Anticoagulation in Patients With Atrial Fibrillation: New Approaches to an Old Problem
2023, Canadian Journal of CardiologyEndovascular management of rectus abdominis hematoma: A report of two cases
2023, Radiology Case ReportsAg nanoparticles/PbTiO<inf>3</inf> with in-situ photocatalytic process and its application in an ultra-sensitive molecularly imprinted hemoglobin detection
2022, Colloids and Surfaces B: BiointerfacesSevere undernutrition increases bleeding risk on vitamin-K antagonists
2021, Clinical NutritionNanomaterials for Fluorescent Detection of Hemoglobin
2024, Critical Reviews in Analytical Chemistry
- 1
Dr. Landefeld is an American College of Physicians George Morris Piersol Teaching and Research Scholar. This work was supported in part by a grant from the National Institute on Aging (RO1 AG09657-01).
Copyright © 1993 Published by Excerpta Medica Inc.